NDC 0069-0345

Paxlovid

Nirmatrelvir And Ritonavir

Paxlovid is a Kit in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is .

Product ID0069-0345_272bc07e-ee0a-48b5-8449-16a24da5670c
NDC0069-0345
Product TypeHuman Prescription Drug
Proprietary NamePaxlovid
Generic NameNirmatrelvir And Ritonavir
Dosage FormKit
Marketing Start Date2022-04-18
Marketing CategoryEMERGENCY USE AUTHORIZATION /
Labeler NamePfizer Laboratories Div Pfizer Inc
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0069-0345-30

5 BLISTER PACK in 1 CARTON (0069-0345-30) > 1 KIT in 1 BLISTER PACK (0069-0345-06) * 4 TABLET, FILM COATED in 1 BLISTER PACK (0069-2085-01) * 2 TABLET, FILM COATED in 1 BLISTER PACK (0069-1345-01)
Marketing Start Date2022-04-18
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Paxlovid" or generic name "Nirmatrelvir And Ritonavir"

NDCBrand NameGeneric Name
0069-0345Paxlovidnirmatrelvir and ritonavir
0069-1085Paxlovidnirmatrelvir and ritonavir
0069-1101Paxlovidnirmatrelvir and ritonavir

Trademark Results [Paxlovid]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PAXLOVID
PAXLOVID
90642654 not registered Live/Pending
Pfizer Inc.
2021-04-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.